Closed Surgical Wound Drainage Market Forecast till 2030
상품코드:1447214
리서치사:Market Research Future
발행일:2024년 02월
페이지 정보:영문 245 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 폐쇄형 수술 후 배액(Closed Type Postoperative Drainage) 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 상환 환경, 시장 규모 추이 및 예측, 각종 부문별/지역별 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
제3장 조사 방법
제4장 시장 역학
개요
성장 촉진요인
성장 억제요인
기회
제5장 시장 요인 분석
밸류체인 분석
Porter's Five Forces 모델
COVID-19가 세계의 폐쇄형 수술 후 배액 시장에 미치는 영향
상환 시나리오
제6장 세계의 폐쇄형 수술 후 배액 시장 : 제품별
개요
폐쇄형 수술후 배액 시스템
부속품
제7장 세계의 폐쇄형 수술 후 배액 시장 : 유형별
개요
액티브 배액
패시브 배액
제8장 세계의 폐쇄형 수술 후 배액 시장 : 연령층별
개요
성인
소아
제9장 세계의 폐쇄형 수술 후 배액 시장 : 용도별
개요
일반 외과
정형외과
심장 및 흉부외과
산과 및 부인과 외과
기타
제10장 세계의 폐쇄형 수술 후 배액 시장 : 최종사용자별
개요
병원 및 진료소
외래수술센터(ASC)
기타
제11장 세계의 폐쇄형 수술 후 배액 시장 : 지역별
개요
북미
유럽
아시아태평양
기타 지역
제12장 경쟁 구도
개요
경쟁 벤치마킹
주요 성장 전략
개발 건수 기준 주요 기업
재무 매트릭스
제13장 기업 개요
CARDINAL HEALTH
ZIMMER BIOMET
AXIOM MEDICAL, INC
ANGIPLAST PVT. LTD
POLYMEDICURE
BECTON, DICKINSON AND COMPANY
B. BRAUN SE
STAYGUARD
MEDLINE INDUSTRIES, INC
VARIVAC INTERNATIONAL MEDICAL RESEARCH PTY LTD
제14장 부록
LSH
영문 목차
영문목차
Cardinal Health (US), Zimmer Biomet (US), Axiom Medical, Inc. (US), Angiplast Pvt. Ltd. (India), Polymedicure (India), Becton, Dickinson, and Company (US), Braun SE (Germany), StayGuard (US), Medline Industries, Inc. (US), and VariVac International Medical Research Pty Ltd. (Australia), Ingelheim (Ingelheim am Rhein, Germany), Vetoquinol (Lure, France), Ceva Animal Health, LLC (Libourne, France), Chanelle Pharma (Galway, Ireland), Elanco (Indiana, US), SOMAVAC Medical Solutions, Inc. (US).
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING INCIDENCE OF CHRONIC WOUNDS AND SURGICAL SITE INFECTIONS
4.2.2 RISING PREVALENCE OF CHRONIC DISEASES
4.2.3 RISING AWARENESS ABOUT THE BENEFITS OF CLOSED SURGICAL WOUND DRAINAGE AND TECHNOLOGICAL ADVANCEMENTS
4.3 RESTRAINTS
4.3.1 INCREASING CONCERNS OVER SIDE EFFECTS
4.3.2 RISE IN THE NUMBER OF MINIMALLY INVASIVE SURGERIES
4.4 OPPORTUNITIES
4.4.1 GROWING AGING POPULATION
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D & DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET
5.3.1 IMPACT ON MARKET GROWTH
5.3.2 DEMAND SUPPLY ANALYSIS
5.3.3 IMPACT ON KEY PLAYERS
5.4 REIMBURSEMENT SCENARIO FOR CLOSED SURGICAL WOUND DRAINAGE
5.4.1 REIMBURSEMENT SCENARIO BY COUNTRY
6 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 CLOSED SURGICAL DRAINAGE SYSTEMS
6.3 ACCESSORIES
7 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY TYPE
7.1 OVERVIEW
7.2 ACTIVE DRAINS
7.3 PASSIVE DRAINS
8 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY AGE GROUP
8.1 OVERVIEW
8.2 ADULT
8.3 PAEDIATRIC
9 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 GENERAL SURGERY
9.3 ORTHOPEDICS SURGERY
9.4 CARDIAC & THORACIC SURGERY
9.5 OBSTETRIC/GYNECOLOGICAL SURGERY
9.6 OTHERS
10 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS & CLINICS
10.3 AMBULATORY SURGICAL CENTERS
10.4 OTHERS
11 GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 UK
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 INDIA
11.4.3 JAPAN
11.4.4 SOUTH KOREA
11.4.5 AUSTRALIA
11.4.6 REST OF ASIA-PACIFIC
11.5 REST OF THE WORLD
11.5.1 AFRICA
11.5.2 LATIN AMERICA
11.5.3 MIDDLE EAST
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET
12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL CLOSED SURGICAL WOUND DRAINAGE MARKET
12.5 FINANCIAL MATRIX
12.5.1 SALES (USD MILLION), 2022
12.5.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022
13 COMPANY PROFILES
13.1 CARDINAL HEALTH
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 PRODUCTS OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 ZIMMER BIOMET
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 PRODUCTS OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 SWOT ANALYSIS
13.2.6 KEY STRATEGIES
13.3 AXIOM MEDICAL, INC
13.3.1 COMPANY OVERVIEWS
13.3.2 FINANCIAL OVERVIEW
13.3.3 PRODUCTS OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 KEY STRATEGIES
13.4 ANGIPLAST PVT. LTD
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 PRODUCTS OFFERED
13.4.4 KEY DEVELOPMENTS
13.4.5 KEY STRATEGIES
13.5 POLYMEDICURE
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 PRODUCTS OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 KEY STRATEGIES
13.6 BECTON, DICKINSON AND COMPANY
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 PRODUCTS OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 SWOT ANALYSIS
13.6.6 KEY STRATEGIES
13.7 B. BRAUN SE
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 PRODUCTS OFFERED
13.7.4 KEY DEVELOPMENTS
13.7.5 SWOT ANALYSIS
13.7.6 KEY STRATEGIES
13.8 STAYGUARD
13.8.1 COMPANY OVERVIEW
13.8.2 PRODUCTS OFFERED
13.8.3 KEY DEVELOPMENTS
13.8.4 KEY STRATEGIES
13.9 MEDLINE INDUSTRIES, INC
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 PRODUCTS OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 SWOT ANALYSIS
13.9.6 KEY STRATEGIES
13.10 VARIVAC INTERNATIONAL MEDICAL RESEARCH PTY LTD
